Moderately to Severely Active Ulcerative Colitis
1 competing product in clinical development for Moderately to Severely Active Ulcerative Colitis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Afimkibart + Placebo | Chugai Pharmaceutical | Phase 3 | Active | 44 |